The synthesis of Bcr-Abl inhibiting anticancer pharmaceutical agents imatinib, nilotinib and dasatinib
出版年份 2012 全文链接
标题
The synthesis of Bcr-Abl inhibiting anticancer pharmaceutical agents imatinib, nilotinib and dasatinib
作者
关键词
-
出版物
ORGANIC & BIOMOLECULAR CHEMISTRY
Volume 11, Issue 11, Pages 1766-1800
出版商
Royal Society of Chemistry (RSC)
发表日期
2012-12-06
DOI
10.1039/c2ob27003j
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- An expeditious synthesis of imatinib and analogues utilising flow chemistry methods
- (2012) Mark D. Hopkin et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- A “Catch–React–Release” Method for the Flow Synthesis of 2-Aminopyrimidines and Preparation of the Imatinib Base
- (2012) Richard J. Ingham et al. ORGANIC LETTERS
- Completely N1-Selective Palladium-Catalyzed Arylation of Unsymmetric Imidazoles: Application to the Synthesis of Nilotinib
- (2011) Satoshi Ueda et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Fit-for-Purpose Development of the Enabling Route to Crizotinib (PF-02341066)
- (2011) Pieter D. de Koning et al. ORGANIC PROCESS RESEARCH & DEVELOPMENT
- Discovery of a Highly Potent and Selective MEK Inhibitor: GSK1120212 (JTP-74057 DMSO Solvate)
- (2011) Hiroyuki Abe et al. ACS Medicinal Chemistry Letters
- Design and synthesis of new anticancer pyrimidines with multiple-kinase inhibitory effect
- (2010) Ibrahim Mustafa El-Deeb et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Synthetic approaches to the 2009 new drugs
- (2010) Kevin K.-C. Liu et al. BIOORGANIC & MEDICINAL CHEMISTRY
- A flow-based synthesis of Imatinib: the API of Gleevec
- (2010) Mark D. Hopkin et al. CHEMICAL COMMUNICATIONS
- Discovery of 3-[2-(Imidazo[1,2-b]pyridazin-3-yl)ethynyl]-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide (AP24534), a Potent, Orally Active Pan-Inhibitor of Breakpoint Cluster Region-Abelson (BCR-ABL) Kinase Including the T315I Gatekeeper Mutant
- (2010) Wei-Sheng Huang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Palladium-catalyzed coupling of functionalized primary and secondary amines with aryl and heteroaryl halides: two ligands suffice in most cases
- (2010) Debabrata Maiti et al. Chemical Science
- Catalytic CC, CN, and CO Ullmann-Type Coupling Reactions
- (2009) Florian Monnier et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Safe transport of cyanamide
- (2009) Klaus-Dieter Wehrstedt et al. JOURNAL OF HAZARDOUS MATERIALS
- Selectively Nonselective Kinase Inhibition: Striking the Right Balance
- (2009) Richard Morphy JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis of imatinib: a convergent approach revisited
- (2009) Andrey S. Ivanov et al. MONATSHEFTE FUR CHEMIE
- Enantioselective Synthesis of Janus Kinase Inhibitor INCB018424 via an Organocatalytic Aza-Michael Reaction
- (2009) Qiyan Lin et al. ORGANIC LETTERS
- Cytoplasmic signalling by the c-Abl tyrosine kinase in normal and cancer cells
- (2008) Audrey Sirvent et al. BIOLOGY OF THE CELL
- Examining the Chirality, Conformation and Selective Kinase Inhibition of 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile (CP-690,550)
- (2008) Jian-kang Jiang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design, Structure−Activity Relationships and in Vivo Characterization of 4-Amino-3-benzimidazol-2-ylhydroquinolin-2-ones: A Novel Class of Receptor Tyrosine Kinase Inhibitors
- (2008) Paul A. Renhowe et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Highly Active Catalyst for Pd-Catalyzed Amination Reactions: Cross-Coupling Reactions Using Aryl Mesylates and the Highly Selective Monoarylation of Primary Amines Using Aryl Chlorides
- (2008) Brett P. Fors et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- A Facile Total Synthesis of Imatinib Base and Its Analogues
- (2008) Yi-Feng Liu et al. ORGANIC PROCESS RESEARCH & DEVELOPMENT
- Development of an Effective Palladium Removal Process for VEGF Oncology Candidate AG13736 and a Simple, Efficient Screening Technique for Scavenger Reagent Identification
- (2008) Erik J. Flahive et al. ORGANIC PROCESS RESEARCH & DEVELOPMENT
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now